Decheng Capital China Life Sciences USD Fund II L.P. 13D and 13G filings for Apexigen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-08 12:18 pm Purchase | 2022-07-29 | 13G | Apexigen, Inc. APGN | Decheng Capital China Life Sciences USD Fund II L.P. | 1,894,551 8.800% | 1,894,551 (New Position) | Filing |